Ballantyne Plastic Surgery Acquired by Alexis Miller and Gen3 Innovations Lab Aesthetics and Wellness Group

Ballantyne Plastic Surgery, a well-established aesthetic surgery practice in Charlotte, North Carolina, has been acquired by Alexis Miller and Gen3 Innovations Lab Aesthetics and Wellness Group, with financial backing from New Majority Capital. The transaction, which took place on May 21, 2026, marks a significant step in the ongoing evolution of the healthcare landscape in Charlotte, particularly for founder-led practices transitioning to new ownership.

Founded by Dr. Thomas G. Liszka over 30 years ago, Ballantyne Plastic Surgery has built a strong reputation for providing patient-centered care and a comprehensive range of aesthetic procedures. Dr. Liszka's decision to sell the practice stems from a desire to ensure its continued growth and success under new leadership. The acquisition aims to leverage Miller's extensive experience in media, entertainment, and technology, as she brings over two decades of expertise from notable companies such as TikTok and Facebook.

Miller's firm, Gen3 Innovations Lab Aesthetics and Wellness Group, operates under the entrepreneurship-through-acquisition (ETA) model, focusing on established businesses that demonstrate strong cash flow. This acquisition aligns with Gen3's strategy to invest in high-quality practices with deep community ties. The partnership with New Majority Capital, an impact investing firm dedicated to supporting underrepresented entrepreneurs, further underscores the commitment to fostering sustainable business growth while preserving the legacy of Ballantyne Plastic Surgery.

This transaction reflects a broader trend in Charlotte's healthcare sector, where many founder-led practices are seeking to transition to next-generation operators. Such transitions are increasingly common as founders look to ensure their practices remain competitive and relevant in a rapidly evolving market. By pairing an experienced operator like Miller with a well-respected institution, the deal aims to maintain the integrity and reputation of Ballantyne Plastic Surgery while positioning it for future expansion.

As the healthcare landscape continues to evolve, the acquisition of Ballantyne Plastic Surgery serves as a case study for similar transactions in the sector. The integration of mission-aligned capital and experienced leadership is crucial for preserving the legacy of established practices while driving innovation and growth. The successful transition of such founder-led businesses will likely encourage other practitioners in the region to consider strategic partnerships that can enhance their operational capabilities and market presence.